How the Plasma Protein Therapeutics Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of thePlasma Protein Therapeutics Market?
The escalation in the frequency of autoimmune diseases is anticipated to stimulate the expansion of the plasma protein therapeutics market in the future. Autoimmune disorders occur when the body’s defense mechanism mistakenly assaults and obliterate its healthy cells. To address such diseases, therapeutic plasma exchanges are often executed. These illnesses result when the body incorrectly perceives a segment of itself as alien and generates proteins, also known as autoantibodies, that assault the part of the body which has been wrongly recognized. For example, in May 2023, a study by the University of Glasgow, a public university in the UK, which encompassed 22 million people, discovered that about 10% of the UK’s population is struck by autoimmune disorders, a figure that surpasses previous approximations. As such, the surge in the incidence of autoimmune disorders is contributing to the growth of the plasma protein therapeutics market in the future.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp
#How Will the CAGR of the Plasma Protein Therapeutics Market Influence Its Overall Growth by 2034?
In recent years, the plasma protein therapeutics market has experienced substantial growth. The market is projected to escalate from $31.86 billion in 2024 to $34.55 billion in 2025, with an 8.5% compound annual growth rate (CAGR). The surge during the historical period is linked to the increasing incidence of rare diseases, an expanding elderly population, a global increase in blood plasma supply, a rise in hemophilia instances, diagnostic advancements, and a regulatory environment that fosters growth.
The market for plasma protein therapeutics is projected to experience robust expansion in the coming years, escalating to $46.35 billion in 2029 with a compound annual growth rate (CAGR) of 7.6%. The projected growth over the forecast period can be credited to advances in gene therapy, higher healthcare spending, more comprehensive indications, precision medicine tactics, and patient access programs. The forecast period is also set to see major trends like technological innovations, the integration of telemedicine, advancements in plasma fractionation technology, the creation of next-generation therapies, the use of recombinant therapies, and personalized medicine strategies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9213
How Are Consumer Market Innovations Shaping the Current and Future Landscape of thePlasma Protein Therapeutics Market?
The proliferation of product advancements is a central trend taking hold in the plasma protein therapeutic market. Leading firms in this sector are channeling innovation to gain leverage in the intensely competitive landscape. For example, Octapharma AG, a Swiss conglomerate, secured approval from European medical regulatory bodies for the freeze-dried variant of their flagship product, octaplasLG, in October 2023. This progressive formulary is designed for the convenience of pre-hospital transfusions, giving healthcare practitioners an optimal management strategy for patients in critical conditions. This approval fortifies Octapharma’s dedication to improve patient healthcare by introducing inventive resolutions in the blood products field.
Who Are the Key Market Players Influencing the Growth of the Corn and Plasma Protein Therapeutics Industry?
Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report
Which Key Market Segments Comprise the Plasma Protein Therapeutics Market and Drive Its Revenue Growth?
The plasma protein therapeutics market covered in this report is segmented –
1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications
Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp
Which Regions Are Emerging as Leaders in the Plasma Protein Therapeutics Market?
North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Plasma Protein Therapeutics Maret 2025, By The Business Research Company:
Blood Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
Rituximab Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
